Bilcare (526853)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a steep discount to book value: P/B of 0.30, with price ₹53.65 versus book value ₹176.58.
• Market capitalization of ₹126 Cr is low relative to latest quarterly sales of ₹181 Cr, offering revenue-based downside if operations stabilise.
• Current price is near the 52-week low of ₹50, suggesting much pessimism is already priced in.
• A positive book value of ₹176.58 per share provides a potential asset cushion, assuming assets are genuinely worth book.

Concerns

• Latest quarter is loss-making: ₹181 Cr sales but ₹13 Cr net loss; P/E is effectively 0.00.
• Fundamentals are deteriorating: sales growth of -8.48% and profit growth of -83.74%.
• Capital returns are far too low: ROE of 2.58% and ROCE of 1.10%, well below any reasonable cost of capital.
• Piotroski F-Score of 3/9, zero dividend yield, and undisclosed debt/equity and promoter holding raise balance-sheet and governance questions.

AI Analysis

Bilcare looks like a classic Graham asset play: the market price of ₹53.65 is barely one-third of the ₹176.58 book value per share. But I have learned to look beyond the balance sheet. This is a business earning a return on equity of just 2.58% and a return on capital of 1.10%, which is far too close to zero for comfort. The most recent quarter tells the real story: ₹181 crore of sales and a ₹13 crore net loss. Sales are shrinking at 8.48% and profits have collapsed by 83.74%. The Piotroski score of 3 out of 9 is a red flag — it points to deteriorating fundamentals, not a company on the mend. A low price-to-book ratio can be a bargain, or it can be a value trap. With zero dividend yield and no promoter holding disclosed, I cannot judge whether insiders are aligned with minority shareholders. I would need to see the debt picture, because the debt-to-equity ratio is not available. Graham taught me to buy with a margin of safety, but that safety comes from earning power and financial strength, not just book value. At this price, investors are paying ₹53.65 for assets that, if the 2.58% ROE were sustained, would earn only about ₹4.56 per share — and that earnings power is now falling. A 1.10% ROCE means management is destroying value relative to the cost of capital. I would wait for evidence that losses are narrowing, that ROCE can climb above the cost of capital, and that the asset base is not being eroded. Until then, this is an interesting but troubled asset play, not a business I would happily own.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer